Cell Biology
Studies from University of Ferrara have provided new information about cell biology
Published in Drug Law Weekly, October 2nd, 2007
A new study, "Cisplatin cytotoxicity in organ of corti-derived immortalized cells," is now available. According to a study from Ferrara, Italy, "Cisplatin is an anticancer drug currently used in the treatment of genital and head and neck tumors. Its use in these and other types of tumors is narrowed by onset of chemoresistance and severe undesired side effects, like as nephro-and ototoxicity, whose mechanisms of action are only partially understood."
"In the present study we investigated the effects of cisplatin (cis-dichlorodiaminoplatin, CDDP) on a cell line (OC-k3) developed from organs of Corti of transgenic mice. We observed at 48 h that cell death due to cisplatin...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2007-10-02)
More Articles from Drug Law Weekly
- Adverse Drug Reactions
Study results from Dartmouth College update understanding of adverse drug reactions - Biotech Business
The Future of Biosimilars: Key Opportunities & Emerging Therapies - Drug Development
Audio: New Survey Finds Strong Public Interest in Prescription Drug Safety Issues - Drug Development
Collin County, Texas Adopts Hythiam's PROMETA Treatment Program - Drug Resistance
Study findings on drug resistance are outlined in reports from A. Kaminski and colleagues - Drug Safety
Pro-Consumer Drug Safety Reforms Agreed to in Final FDA Bill; Should End Drug Industry Gaming of Safety System - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
